EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Editor's Choice – Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change

Shigeo Ichihashi, Mitsuyoshi Takahara, Naoki Fujimura, Hiroshi Banno, Seiji Onitsuka, Masami Shingaki, Terutoshi Yamaoka, Makoto Sumi, Osamu Iida, Shinichi Iwakoshi, Stephan Haulon, Kimihiko Kichikawa und 1 weitere

European Journal of Vascular and Endovascular Surgery · 2025

DOI: 10.1016/j.ejvs.2025.04.028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Shigeo Ichihashi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Nara Medical University, Nara, Japan. Electronic address: shigeoichivasc@gmail.com. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Embolization, Therapeutic, Endovascular Procedures, Mesenteric Artery, Inferior. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Boston Scientific Japan, Terumo Corporation, W L Gore & Associates Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Persistent type II endoleak (T2EL) following endovascular aortic aneurysm repair (EVAR) has been identified as a cause of aneurysm sac expansion, leading to re-intervention and aneurysm rupture. The role of pre-emptive inferior mesenteric artery (IMA) embolisation to prevent T2EL and sac expansion remains controversial. This study aimed to evaluate the influence of IMA embolisation on aneurysm sac change after EVAR. METHODS: The CLARIFY IMA study was a multicentre randomised controlled trial conducted at 24 centres and was registered in the UMIN Clinical Trials Registry (UMIN000035502). Patients with a fusiform abdominal aortic aneurysm (AAA) were randomised to undergo EVAR with or without pre-emptive IMA embolisation. The primary outcome was the percentage change in computed tomography (CT) assessed aneurysm sac volume at 12 months, with secondary outcomes including sac diameter changes, prevalence of T2EL, freedom from re-intervention, and overall survival at six, 12, and 24 months. All CT data were evaluated at the core laboratory using a 3D workstation. RESULTS: One hundred and thirty-eight patients with AAA (mean age ± standard deviation 76 ± 8 years; 117 men) were randomised to the IMA embolisation (n = 70) or control groups (n = 68). IMA embolisation was successful in 63 (90%) of 70 patients, without any adverse events. At 12 months there was no statistically significant difference in aneurysm sac volume change between the embolisation group (mean -3.90 ± 14.19%) and control group (mean -3.56 ± 13.91%) (p = .89). Furthermore, no statistically significant differences were observed in sac diameter change, rates of T2EL, freedom from re-intervention, and overall survival at any follow up time point. CONCLUSION: Pre-emptive IMA embolisation did not significantly impact the change in aneurysm sac volume, T2EL or re-intervention rates compared with controls at 24 month follow up. Further research may be necessary to fully assess the impact of pre-emptive IMA embolisation on clinical outcomes following EVAR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalEmbolization, TherapeuticEndovascular ProceduresMesenteric Artery, InferiorEndoleakBlood Vessel Prosthesis ImplantationHumansMaleFemaleAgedTreatment OutcomeAged, 80 and overComputed Tomography Angiography

Stichwörter der Autor:innen

Abdominal aortic aneurysmEVAREmbolisationEndovascular aneurysm repairInferior mesenteric artery

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Nara Medical University, Nara, Japan. Electronic address: shigeoichivasc@gmail.com.
  • Department of Diabetes Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Surgery, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Cardiovascular Surgery, Hakodate Municipal Hospital, Hokkaido, Japan.

Förderung

  • Boston Scientific Japan
  • Terumo Corporation
  • W L Gore & Associates Inc

Zitieren

APA

Ichihashi, S., Takahara, M., Fujimura, N., Banno, H., Onitsuka, S., Shingaki, M., Yamaoka, T., Sumi, M., Iida, O., Iwakoshi, S., Haulon, S., Kichikawa, K., & CLARIFY IMA Investigators (2025). Editor's Choice – Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.04.028

Vancouver

Ichihashi S, Takahara M, Fujimura N, Banno H, Onitsuka S, Shingaki M, et al. Editor's Choice – Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.04.028

BibTeX
@article{Ichihashi2025,
  author = {Ichihashi, Shigeo and Takahara, Mitsuyoshi and Fujimura, Naoki and Banno, Hiroshi and Onitsuka, Seiji and Shingaki, Masami and Yamaoka, Terutoshi and Sumi, Makoto and Iida, Osamu and Iwakoshi, Shinichi and Haulon, Stephan and Kichikawa, Kimihiko and CLARIFY IMA Investigators, CLARIFY IMA Investigators},
  title = {Editor's Choice – Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2025},
  doi = {10.1016/j.ejvs.2025.04.028}
}
Kostenlos starten →